Cystoscopic injections of dextranomer hyaluronic acid into proximal urethra for urethral incompetence: efficacy and adverse outcomes.
Lightner
Deborah J
DJ
Department of Urology, Mayo Clinic Graduate School of Medicine, Rochester, Minnesota 55905, USA. Lightner.deborah@mayo.edu
Fox
Janelle
J
Klingele
Christopher
C
D000328:Adult; D000368:Aged; D015331:Cohort Studies; D003558:Cystoscopy / Q000379:methods; D003911:Dextrans / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006820:Hyaluronic Acid / Q000009:adverse effects / Q000627:therapeutic use*; D015552:Injections, Intralesional; D008297:Male; D008875:Middle Aged; D011788:Quality of Life; D012189:Retrospective Studies; D018570:Risk Assessment; D017751:Safety Management; D012720:Severity of Illness Index; D016896:Treatment Outcome; D014521:Urethra / Q000187:drug effects* / Q000503:physiopathology; D014563:Urodynamics; D014718:Vesico-Ureteral Reflux / Q000175:diagnosis / Q000188:drug therapy*
D003911:Dextrans; C013471:dextranomer; D006820:Hyaluronic Acid